Shiny Health & Wellness Corp. SNYB, a provider of premium cannabis products in Canada, has unveiled its second-quarter fiscal year 2024 financial results for the three months ending July 31, 2023.
Additionally, the company has announced the closing of the Turbo Holdings partnership.
Q2 Overall Performance
- Sales experienced a decrease during the period ending July 31, 2023, primarily due to the reduction in the company's cannabis retail store count, which decreased from 31 to 26 stores.
- Shiny Health's Q2 FY2024 results reveal a net comprehensive loss of $2.1 million, based on sales of $6.2 million.
- Gross profit for the same period amounted to $2.1 million while operating expenses stood at $3.1 million.
- Other expenses totaled $1.1 million with an additional other comprehensive gain of $0.04 million.
- For the six months ending July 31, 2023, the company reported a net comprehensive loss of $2.8 million based on sales of $12.6 million, with a gross profit of $4.5 million and operating expenses of $6.2 million.
- Salaries and benefits expenses declined by 18.0% for the Q2 period in 2023 compared to the same period in 2022, attributed to reduced corporate headcount and share-based compensation.
Turbo Partnership Closure
- The company announced the closing of the Asset Purchase Agreement with an affiliate of Turbo Holdings Canada Inc., combined with a new Trademark License Agreement.
- The transaction involved the sale of two of Shiny Health's retail locations for an estimated total purchase price of $800,000.
- Under the Trademark License Agreement, the affiliate of Turbo Holdings obtained the right to operate these stores under the "ShinyBud" trademark.
- Turbo Holdings has secured Alcohol Gaming Commission of Ontario (AGCO) approvals, and the adult-use dispensaries are open for business.
- A portion of the proceeds from this partnership closure has been allocated to debt repayment.
Now Read: Layoffs & Facility Sales Save Millions For This Cannabis Producer As It Eyes European Market
Image by El Planteo
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.